Shh (Sonic Hedgehog) is a morphogen involved in gastric fundic gland differentiation in the adult. Shh expression is reduced in Helicobacter pylori-associated intestinal metaplastic change of the gastric epithelium and mice that lack Shh show intestinal transformation of the gastric mucosa. Similarly, in the stomach of Cdx2 (caudal-type homeobox 2)-transgenic mice, the gastric mucosa is replaced by intestinal metaplastic mucosa. The aim of the present study was to use Cdx2-transgenic mice to investigate: (i) Shh expression in the intestinal metaplastic mucosa of the Cdx2-transgenic mouse stomach; and (ii) the relationship between Shh and Cdx2. We determined that Shh mRNA levels were dramatically reduced in the intestinal metaplastic mucosa of the Cdx2-transgenic mouse stomach compared with the normal (wildtype) mouse stomach. This was not due to hypermethylation of the Shh promoter, but instead we showed that Cdx2 directly bound to the TATA box region of the Shh promoter. Cdx2 also down-regulated transcription of the Shh gene in the human gastric carcinoma cell lines AGS, MKN45 and MKN74. In conclusion, Cdx2 reduced Shh expression by binding to the unmethylated Shh promoter in the intestinal metaplastic mucosa of Cdx2-transgenic mouse stomach.
INTRODUCTION
Members of the Hh (Hedgehog) family of morphogens play an important role in the development and homoeostasis of the gastrointestinal mucosa. Mammals have three Hh genes: Shh (Sonic Hedgehog), Ihh (Indian Hedgehog) and Dhh (Desert Hedgehog). The Hh signalling pathway is critical for normal mammalian gastrointestinal development. Through epithelialmesenchymal interactions, Hh signalling ensures appropriate axial patterning of the embryonic gut. In adults, there is evidence that the pathway plays a role in maintaining stem cell populations in the stomach. In humans and mice, Shh mRNA and Shh protein are expressed in the normal (wild-type) gastric fundus. The gastric mucosa of Shh-null mice shows epithelial hyperplasia and alkaline phosphatase expression, a sign of intestinal-type differentiation [1] . Shh expression is lost in intestinal metaplasia of the stomach and increased in fundic gland ectopies, such as gastric metaplasia of the oesophagus and Meckel's diverticulum [2, 3] .
Intestinal metaplasia of the human stomach has been extensively studied as a possible premalignant condition [4] [5] [6] [7] . The intestine-specific homeobox gene Cdx2 (caudal-type homeobox 2) has been shown to be aberrantly expressed in intestinal metaplasia. Cdx2 is a mammalian member of the caudal-related homeobox gene family [8] . In the adult mouse, and in humans, expression is strictly confined to the gut, from the duodenum to the rectum. The stomach does not normally express the transcription factor Cdx2. We and others have reported the presence of Cdx2 in the intestinal metaplastic mucosa of Helicobacter pylori-infected human stomach [9] [10] [11] [12] . In addition, we generated Cdx2-transgenic mice that developed intestinal metaplastic mucosa in the stomach [13, 14] .
H. pylori infection is known to be one of the major virulence factors interfering with the differentiation of the fundic glands by causing chronic inflammation [15] . H. pylori infection is associated with reduced expression of Shh in the fundic glands. The loss of Shh and the aberrant expression of Cdx2 are early changes that occur in the intestinal metaplastic mucosa [16] . There is an inverse correlation between Shh expression and the degree of H. pylori-associated gastric mucosal damage. In contrast, there is a direct correlation between Cdx2 expression and the presence of atrophy and intestinal metaplasia. H. pylori eradication is associated with an increase in Shh expression and a decrease in Cdx2 expression in the gastric mucosa [16] . Shh and Cdx2 appear to play opposing roles, with Shh being essential for fundic gland differentiation and Cdx2 being required for conversion into an intestinal metaplastic phenotype. In a Mongolian-gerbil model it has been shown that H. pylori infection leads to downregulation of Shh expression [17] . However, the relationship between Shh down-regulation and Cdx2 up-regulation in the intestinal metaplastic mucosa has not yet been clarified.
In the present study, the Cdx2-transgenic mouse model of intestinal metaplasia of the stomach was used to examine the relationship between Shh and Cdx2 in the intestinal metaplastic mucosa.
EXPERIMENTAL

Cdx2-transgenic mice
Cdx2-transgenic mice, with stomach-specific expression of Cdx2 under the control of the rat Atp4b (H + /K + -ATPase β-subunit) gene promoter were used [13] . The gastric mucosa of these Abbreviations used: Atp4, H + /K + -ATPase; Bmp, bone morphogenetic protein; Cabp9k, calbindin-D9K; Cdx, caudal-type homeobox; ChIP, chromatin immunoprecipitation; DIG, digoxigenin; DTT, dithiothreitol; EMSA, electrophoretic mobility-shift assay; Gli1, GLI/Krüppel family member GLI1; Hh, Hedgehog; HRP, horseradish peroxidase; Ihh, Indian Hh; ISH, in situ hybridization; Muc6, mucin 6; Ptch1, patched homologue 1; qRT-PCR, quantitative real-time PCR; Shh, Sonic Hh; siRNA, small interfering RNA; TBS, Tris-buffered saline; TBST, TBS containing 0.1 % Tween 20; TFIID, transcription factor IID. 1 To whom correspondence should be addressed (email muto@jichi.ac.jp).
mice is completely transformed into intestinal metaplastic mucosa [13, 14] . Mice had free access to standard food and drinking water and were maintained on a 12 h light/12 h dark cycle. All experiments involving animals in the present study were performed in accordance with the Jichi Medical University Guide for Laboratory Animals.
RNA isolation and qRT-PCR (quantitative real-time PCR)
Total RNA was extracted from the gastric mucosa (normal mice), the intestinal metaplastic mucosa (Cdx2-transgenic mice) and the cell lines AGS, MKN45 and MKN74 using the guanidinium isothiocyanate/phenol method (Isogen; Nippon Gene) according to the manufacturer's instructions. Total RNA (1 μg) was reverse-transcribed at 37
• C for 1 h in a final volume of 20 μl of reverse transcription buffer [50 mM Tris/HCl, pH 8.3, containing 50 mM KCl, 10 mM MgCl 2 , 0.5 mM spermidine and 10 mM DTT (dithiothreitol)] containing reverse transcriptase (ReverTraAce; Toyobo), 200 pmol of random primers and 1 mM dNTPs (Sigma-Aldrich). The cDNA (100 ng) was then used in each real-time PCR to determine the expression levels for each specific gene. The PCR was performed using the following ready-to-use Assay-on-Demand Applied Biosystems gene expression products: Cdx2 (mouse), Mm00432449_ml; CDX2 (human), Hs01078080_m1; Shh (mouse), Mm00436528_m1; SHH (human), Hs01123832_m1; Ihh, Mm01259021_m1; Bmp2 (bone morphogenetic protein 2), Mm01962382_s1; Bmp4, Mm01321704_m1; Ptch1 (patched homologue 1), Mm01306905_m1; Gli1 (GLI-Krüppel family member GLI1) and Mm00494654_m1. Each Assay-on-Demand gene expression product contains target-specific primers and probes and a TaqMan Gene Expression Master Mix containing AmpErase uracil-N-glycosylase to prevent re-amplification of carry-over PCR products. PCR amplification and fluorescence data collection were performed with an ABI PRISM 7900 HT sequence detection system (Applied Biosystems), using the following conditions: 50
• C for 2 min, 95
• C for 10 min, and then 40 cycles of amplification (95
• C for 15 s and 60
• C for 1 min). All PCRs were performed in 96-well plates using a final volume of 20 μl and each gene was studied in triplicate. To normalize RNA transcript abundance for each gene, the housekeeping genes encoding β-actin (mouse) or GAPDH (glyceraldehyde-3-phosphate dehydrogenase) (human) were used to calculate the C T [C T (target)/C T (actin)]. The C T values for β-actin for the normal and Cdx2-transgenic mouse stomach tissues fell in a close range with no specific pattern of spatial or temporal variation detected (results not shown). A relative quantification approach was used in the present study to describe the change in expression of the target gene in a test sample relative to a calibrator sample (reference). The relative RNA transcript abundance value was calculated as follows: first, the C T for the normal and Cdx2-transgenic mouse stomach tissues was calculated; and secondly, differences between the normal and Cdx2-transgenic mouse stomach tissues were calculated as
. The normal mouse stomach was used as the reference for Shh, Bmp4, Bmp2 and Ptch1 expression, and the Cdx2-transgenic mouse stomach was used as the reference for Cdx2 expression. Finally, the fold difference (relative abundance) was calculated using the formula 2 − C T [18] and was plotted as the mean (n = 6).
ISH (in situ hybridization)
Paraffin-embedding blocks and sections of mouse stomach for ISH were obtained from Genostaff. The mouse stomach was dissected, fixed with tissue fixative (Genostaff), embedded in paraffin according to the manufacturer's protocols and sectioned at 5 μm. For ISH, tissue sections were de-waxed with xylene and rehydrated through an ethanol series and PBS. The sections were fixed with 4 % (w/v) paraformaldehyde in PBS for 15 min and then washed with PBS. The sections were treated with 8 μg/ml proteinase K in PBS for 30 min at 37
• C, washed with PBS, re-fixed with 4 % (w/v) paraformaldehyde in PBS, washed again with PBS, and placed in 0.2 M HCl for 10 min. After washing with PBS, the sections were acetylated by incubation in 0.1 M triethanolamine/HCl, pH 8.0, containing 0.25 % acetic anhydride for 10 min. After washing with PBS, the sections were dehydrated through an ethanol series. The probe for the 1238-bp cDNA fragment, from positions +369 to +1606 of the Shh cDNA, was labelled using a DIG (digoxigenin) RNAlabelling kit (Roche). Hybridization was performed with probes at concentrations of 300 ng/ml in Probe Diluent-1 (Genostaff) at 60
• C for 16 h. After hybridization, the sections were washed in 5 × HybriWash (Genostaff), which is equivalent to 5 × SSC [1 × SSC is 0.15 M NaCl/0.015 M sodium citrate], at 60
• C for 20 min, and then in 50 % (v/v) formamide and 2 × HybriWash at 60
• C for 20 min, followed by RNase treatment (50 μg/ml RNaseA in 10 mM Tris/HCl, pH 8.0, 1 M NaCl and 1 mM EDTA for 30 min at 37
• C). Then the sections were washed twice with 2 × HybriWash at 60
• C for 20 min, twice in 0.2 × HybriWash at 60
• C for 20 min, and once with TBST [TBS (Tris-buffered saline) and 0.1 % Tween 20]. After treatment with 0.5 % blocking reagent (Roche) in TBST for 30 min, the sections were incubated with an anti-DIG antibody conjugated to alkaline phosphatase (Roche), diluted 1:1000 in TBST and incubated for 2 h at room temperature (20 • C). The sections were washed twice with TBST and then incubated in 100 mM Tris/HCl, pH 9.5, containing 100 mM NaCl, 50 mM MgCl 2 and 0.1 % Tween 20. Colouring reactions were performed with NBT/BCIP (Nitro Blue Tetrazolium/5-bromo-4-chloroindol-3-yl phosphate) solution (Sigma-Aldrich) overnight followed by washing with PBS. The sections were counterstained with Kernechtrot stain solution (Muto Pure Chemicals), dehydrated and then mounted with Malinol (Muto Pure Chemicals).
Immunohistochemistry
Murine tissues sectioned at a thickness of 3 μm were used for immunohistochemistry as described previously [13, 14] . Primary antisera were diluted in PBS and incubated overnight at 4
• C. The next day, slides were washed in PBS and incubated with Cy3 (indocarbocyanine)-conjugated secondary antibodies to detect the primary goat antibodies (for immunofluorescence) or HRP (horseradish peroxidase)-labelled secondary antibodies to detect the primary mouse antibodies, at 37
• C for 30 min. Colour development was carried out by incubating the sections with DAB (3,3-diaminobenzidine tetrahydrochloride; Wako Pure Chemical Industries) as the chromogenic substrate. Finally, the sections were lightly counterstained with haematoxylin, mounted and viewed under a light microscope.
Our panel of primary antisera included the anti-H + /K + -ATPase antibody (dilution of 1:100, mouse IgG; developed in-house) and the anti-Muc6 (mucin 6) antibody (dilution of 1:50, mouse IgG; Kanto Chemical).
Bisulfite sequencing for the Shh promoter
The methylation status of gene promoter CpGs is best analysed using direct sequencing after sodium bisulfite modification of target DNA (bisulfite sequencing). DNA (1 μg of DNA per sample) was sodium-bisulfite-modified with a Table 1 ). The primer pairs were designed to bind sequences lacking any CpGs, therefore avoiding any preferential amplification of methylated or unmethylated DNA strands. The PCR products were purified using GenElute ® agarose spin columns (Sigma-Aldrich) and the purified products were used for cloning using a Topo ® TA cloning kit (Invitrogen). Direct sequencing was performed using a BigDye ® terminator cycle sequencing kit (Applied Biosystems) and a fluorescent sequencer ABI 377 (Applied Biosystems).
ChIP (chromatin immunoprecipitation) assay
The mucosa removed from the normal mouse stomach and intestine, the mucosa removed from the Cdx2-transgenic mouse stomach (pedigrees no. 17 • C. The supernatant was collected and coimmunoprecipitated DNA was recovered. qRT-PCR (for primers see Table 1 ) was used for the ChIP assays. All ChIP assays were repeated at least three times. We also examined the ability of Cdx2 to bind to the Shh promoter sequence 2 kb upstream of the transcription start site, using ChIP assays with four sets of primer pairs (FW1-FW4 and RV1-RV4; Table 1 ).
Luciferase assays
To construct the luciferase reporter vectors, pGL4.10[luc2]-Shh, 925-bp ( − 792 to +133) and 763-bp ( − 792 to − 30) fragments, located at the 5 end of the mouse Shh coding sequence, were amplified by PCR with specific primers (Table 1 ) from 500 ng of mouse genomic DNA isolated from mouse tails using standard phenol/chloroform extraction procedures. The amplified fragments of the Shh promoter were directly cloned into the TA cloning vector pCRII (Invitrogen) to yield the plasmid pCRII/Shh promoter. Each pCRII/Shh promoter construct was digested with KpnI and SacI (Table 1) , and the resulting fragments were subcloned into the KpnI and SacI restriction sites of the pGL4. 10 [luc2] vector (Promega) and confirmed by sequence analysis.
The human gastric cancer cell lines AGS, MKN45 and MKN74 were maintained in DMEM (Dulbecco's modified Eagle's medium) supplemented with 1 mM L-glutamine, 10 % (w/v) fetal bovine serum and 1 % (v/v) antibiotic solution (Invitrogen). AGS, MKN45 and MKN74 cells were seeded at 2 × 10 5 cells/well in 24-well dishes (Nunc), 18-24 h before transfection. Transient transfections were performed using Lipofectamine TM 2000 (Invitrogen) according to the manufacturer's instructions. Shh promoter reporter plasmids (100 ng) were added to each plate, together with 50 ng of the Renilla luciferase reporter plasmid (pGL4.70[hRluc]; Promega) as a control for the transfection efficiency. At 24 h after the transfection, the cells were lysed in lysis buffer (Promega) and the firefly and Renilla luciferase activities were measured using the dual-luciferase reporter assay system (Promega) in a luminometer, according to the manufacturer's instructions. The relative firefly luciferase activities were calculated by normalizing the transfection efficiency according to the Renilla luciferase activities produced by the internal control plasmid pGL4.70 [hRluc] . Three separate experiments were carried out in triplicate.
siRNA (small interfering RNA) transfection
AGS, MKN45 and MKN74 cells were plated in 10-cmdiameter plates, 24 h before transfection. Transfections were performed using the Lipofectamine TM 2000 reagent, following the manufacturer's protocol (Invitrogen), with 10 nM of the siRNA Silencer ® Select pre-designed siRNA (Applied Biosystems; no. s2878; 5 -UUCUUGUUGAUUUUCCUCUcc-3 ) or Silencer ® Select negative control (no. 4390843).
Cdx2 mutant plasmids
The plasmid encoding the mutant form of Cdx2, with the homeodomain linked to the N-terminal domain, was constructed using the PCR primers Cdx2-fw-1 and Cdx2-rv-1 (Table 1) . Platinum ® Taq high-fidelity DNA polymerase (Invitrogen) was used for PCR.
Protein isolation and immunoblotting
Cells were washed twice with ice-cold PBS, scraped into RIPA buffer (50 mM Tris/HCl, pH 7.6, containing 150 mM NaCl, 1 % Nonidet P-40 and 1 mM DTT) containing a protease inhibitor cocktail (Sigma-Aldrich) and incubated on ice for 10 min. The collected cells were then briefly sonicated [60 W for 3 min (1 min sonication followed by 1 min interval); Ultra S homogenizer VP-5S; TAITEC] and centrifuged at 14 000 g for 10 min at 4
• C to remove cellular debris. The protein concentration of each freshly prepared cell lysate was determined using the Bradford assay (Bio-Rad Laboratories). After mixing with an equal volume of 2 × Laemmli sample buffer (Bio-Rad Laboratories), cell lysates containing equal amounts of supernatant protein were loaded in each lane, fractionated by SDS/PAGE (10 % gels) on a MiniGel apparatus (Bio-Rad Laboratories), and electrotransferred on to PVDF membranes (Millipore) using a semi-dry transfer cell (Bio-Rad Laboratories). Transblotted membranes were washed twice with TBST. After blocking with TBS containing 3 % (w/v) low-fat milk for 30 min, membranes were probed with rabbit monoclonal antibodies against Cdx2 (Epitomics) in TBS containing 1 % (w/v) low-fat milk at room temperature for 2 h, and washed twice with TBST. Following incubation with a secondary antibody conjugated to HRP for 1 h at room temperature and two washes with TBST, protein bands were detected by ECL (enhanced chemiluminescence; Amersham Biosciences).
EMSA (electrophoretic mobility-shift assay)
Nuclear fractions were extracted for EMSA from AGS cells transfected with full-length Cdx2 or Cdx2 C. To extract nuclear fractions for EMSA studies, AGS cells were washed in PBS, subjected to swelling in 400 μl of hypotonic buffer A (10 mM Hepes, pH 7.9, containing 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA and 1 mM DTT) supplemented with protease inhibitor cocktail and lysed [27] . Then, 25 μl of 10% (v/v) Nonidet P-40 solution was added, and nuclear fractions were collected by sedimentation for 5 min at 500 g. Supernatants were discarded and precipitated nuclei were resuspended in 100 μl of buffer C (20 mM Hepes, pH 7.9, containing 400 mM NaCl, 1 mM DTT, 1 mM EDTA, 1 mM EGTA and protease inhibitor cocktail) and centrifuged for 5 min at 14 000 g. Supernatants containing nuclear proteins were collected and tested for their ability to bind labelled nucleotides corresponding to the Shh promoter. All DNA-protein binding reaction protocols were according to the manufacturer's instructions (Promega). The double-stranded DNA probes used in the EMSAs are described in Table 1 . Briefly, 0.5 ng of 32 Plabelled probe was incubated for 20 min at 4
• C with 5 μg of nuclear extract in the presence of 1 × gel-shift buffer (Promega). Subsequently, 1.5 μl of 10 × loading buffer (50 % glycerol, 0.5 % Bromophenol Blue and 0.1 % Xylene Cyanol) were added to the reaction mixtures, and the products were then separated by PAGE (in 5 % non-denaturing gels) until the unbound probe was close to the bottom of the gel. Specificity of protein-DNA interaction was confirmed by competition with a 100 × excess amount of unlabelled competitors.
RESULTS
Reciprocal expression of Shh and Cdx2 in the intestinal metaplastic mucosa of Cdx2-transgenic mouse stomach
In the Cdx2-transgenic mice we generated previously, all of the epithelial cells in the gastric corpus expressed Cdx2 and were replaced by intestinal metaplastic cells [13, 14] . First, we examined Cdx2 expression in the intestinal metaplastic mucosa of Cdx2-transgenic mouse stomach using qRT-PCR ( Figure 1A) . The Cdx2 mRNA level in the Cdx2-transgenic mouse stomach was increased 2800-fold compared with the normal mouse stomach ( Figure 1A ). As Shh expression is lost in the intestinal metaplasia of the human stomach, we next examined Shh expression in the Cdx2-induced intestinal metaplastic mucosa of the Cdx2-transgenic mice [3] . Shh gene expression was measured by qRT-PCR ( Figure 1B) . The Shh mRNA level in the Cdx2-transgenic mouse stomach was reduced 1450-fold compared with the normal mouse stomach ( Figure 1B) . The expression level of another Hh gene Ihh, in the intestinal metaplastic mucosa of Cdx2-transgenic mouse stomach was the same as that in the normal mouse stomach ( Figure 1C) .
Furthermore, we investigated Shh expression in the gastric mucosa of the normal mouse stomach and in the intestinal metaplastic mucosa of the Cdx2-transgenic mouse stomach using ISH. Shh was expressed in the gastric fundic mucosa of the normal mouse stomach ( Figures 1D, 1E and 1H ), but not in the intestinal metaplastic mucosa of the Cdx2-transgenic mouse stomach ( Figures 1F and 1G) . The reduced expression of Shh mRNA in the intestinal metaplastic mucosa of the Cdx2-transgenic mouse stomach indicates that Shh might be reduced by Cdx2 in intestinal metaplastic mucosa.
Shh is a morphogen involved in gastric fundic gland differentiation. Next, we examined the Atp4-positive parietal cells in both normal and Cdx2-transgenic mouse stomach (Figures 2A  and 2B ). The normal gastric fundic glands expressing Shh ( Figures 1C and 1E) were positive for Atp4 (Figure 2A ). On the other hand, the intestinal metaplastic mucosa of Cdx2-transgenic mouse stomach, which did not express Shh ( Figures 1G  and 1H) , had lost the Atp4-positive parietal cells ( Figure 2B ). Muc6 production is turned off as the mucous neck cells migrate towards the base of the fundic glands and transdifferentiate into pepsinogen-producing zymogenic cells [19] . We examined Muc6 expression in both the normal and the Cdx2-transgenic mouse stomach (Figures 2C and 2D) . Muc6 was expressed in the mucous neck cells of the normal gastric mucosa ( Figure 2C ) but in the Cdx2-transgenic mouse stomach, the Muc6-positive cells were located at the base of the intestinal metaplastic mucosa ( Figure 2D ). This indicates that the mucous neck cells cannot differentiate to the parietal cells and chief cells that are transdifferentiated towards the base of the fundic glands.
Next, we investigated whether the Shh-downstream target genes Gli1, Bmp4 and Ptch1 were expressed in Cdx2-induced intestinal metaplastic mucosa. Bmp4, Ptch1 and Gli1 were reduced in the Cdx2-induced intestinal metaplastic mucosa, compared with the normal gastric mucosa ( Figures 3A, 3C and 3D) . Bmp2, which is not a Shh-downstream target gene, was also reduced in the Cdx2-induced intestinal metaplastic mucosa ( Figure 3B ).
Shh promoter methylation status
We focused on epigenetic regulation of Shh gene expression as a possible cause of the reduced expression of Shh in the intestinal metaplastic mucosa of Cdx2-transgenic mouse stomach. To investigate whether the differences in Shh expression were under promoter methylation control, bisulfite sequencing was performed on DNA extracted from the gastric mucosa of normal mice and from the intestinal metaplastic mucosa of the Cdx2-transgenic mouse stomach. The Shh promoter region was unmethylated in both the intestinal metaplastic mucosa and the normal gastric mucosa (Figure 4) . All of the CpGs (highlighted in grey in Figure 4 ) in the Shh promoter sequence from the intestinal metaplastic mucosa and the normal gastric mucosa were unmethylated. These results clarify that the Shh promoter methylation status does not mediate the reduced expression of Shh in the intestinal metaplastic mucosa of the Cdx2-transgenic mouse stomach.
Cdx2 binds directly to the Shh promoter region in vivo
The putative TATA box (TATATAG) sequence at positions − 18 to − 12 (relative to the transcription start site) exhibits obvious sequence similarity with the consensus Cdx-binding site (C/TATAAAG/T) and no additional putative Cdx-binding site could be found elsewhere in the Shh promoter ( Figure 5A ). To examine whether the reduced expression of Shh mRNA in the intestinal metaplastic mucosa of Cdx2-transgenic mouse stomach is associated with the binding of Cdx2 to this TATATAG region, we performed ChIP assays using an antibody against Cdx2. We therefore cross-linked protein-DNA interactions in the intestinal metaplastic mucosa of the Cdx2-transgenic mouse stomach, as well as in the gastric and intestinal mucosa of normal mice. qRT-PCR with Shh-ChIP-fw-2, Shh-ChIP-rv-2 and the TaqMan-MGB-probe-2 (primer positions are indicated in Figure 5A and sequences are given in Table 1 ), revealed binding of Cdx2 to the promoter region of the Shh gene in the intestinal metaplastic mucosa of Cdx2-transgenic mouse stomach, but not in the gastric mucosa of normal mice ( Figure 5B ). However, qRT-PCR with primers Shh-ChIP-fw-1,Shh-ChIP-rv-1 and the TaqMan-MGB-probe-1 ( Figure 5A and Table 1 ), revealed that there was no binding of Cdx2 to the promoter region of the Shh gene in either the intestinal metaplastic mucosa of Cdx2-transgenic mouse stomach or in the gastric mucosa of normal mice ( Figure 5C ). As binding was only detected using primers from the proximal promoter sequence, we infer that Cdx2 binds to a region near to the promoter region that contains the Cdx-consensus-binding sequence TATATAG ( Figure 5A ).
Furthermore, we examined the binding of Cdx2 to the TATATAG sequence in the intestinal metaplastic mucosa derived from Cdx2-transgenic mice with different expression levels of Cdx2. Using qRT-PCR, we showed that the Cdx2-transgenic mouse stomach (from pedigree no. 17, which was used elsewhere in the present study) expressed 5-fold more Cdx2 than the Cdx2-transgenic mouse stomach from pedigree no. 53 (results not shown). The qRT-PCR for the ChIP assay showed that Cdx2 also bound to the sequence containing TATATAG in the intestinal metaplastic mucosa of pedigree no. 53 ( Figure 5B) .
We also examined the ability of Cdx2 to bind to the Shh promoter sequence 2 kb upstream of the transcription start site, using ChIP assays with four sets of primer pairs. We were not able to detect obvious binding of Cdx2 to any of these four regions by ChIP assay (results not shown).
We investigated the Cdx2 binding to the TATATAG sequence, using nuclear fractions extracted from AGS cells transfected with full-length Cdx2 or Cdx2 C ( Figure 5D and Figure 6C ). We found that nuclear extracts from Cdx2-transfected AGS cells formed the Cdx2-DNA complex ( Figure 5D , lane 2). Although excess unlabelled competitor was able to compete with the nuclear protein binding ( Figure 5D, lane 4) , excess unlabelled mutant competitor failed to compete with the Cdx2 binding ( Figure 5D , lane 5), suggesting that the 28-bp sequence containing TATATAG binds Cdx2. In a Western blot analysis, the intrinsic Cdx2 level of AGS cells was very low compared with the AGS cells transfected with Cdx2-expression plasmid (results not shown) and we hypothsize that this very low intrinsic Cdx2 expression might be the reason endogenous binding of Cdx2 to the probe was not detected in the EMSAs ( Figure 5D, lane 1) . Using a mutant probe, we demonstrated that DNA-protein complexes were not formed either in Cdx2-transfected AGS cells ( Figure 5D , lane 3) or in mutant Cdx2-transfected AGS cells ( Figure 5D, lane 6) . Both Cdx2-transfected and mutant Cdx2-transfected AGS cells expressed equal amount of protein ( Figure 6C ). These results indicate that Cdx2 binds to the TATATA sequence.
The Shh promoter is activated in Cdx2-expressing human gastric carcinoma AGS, MKN45 and MKN74 cells
We next examined Shh transcriptional activity in Cdx2-expressing AGS, MKN45 and MKN74 cells, using pGL4.10[luc2]-Shh reporter constructs. First, we examined the expression of Cdx2 in AGS, MKN45 and MKN74 cells using qRT-PCR. All three cell types expressed Cdx2 ( Figure 6A) [we chose these three cell lines because they expressed different levels of Cdx2 ( Figure 6A ) and Shh ( Figure 6B ): MKN45 has high Shh and low Cdx2 expression; MKN74 has low Shh and low Cdx2 expression; and AGS has low Shh and high Cdx2 expression]. Next, after transfection of siRNA against Cdx2, Shh mRNA levels were measured using qRT-PCR. Western blot analysis showed that transfection of the siRNA against Cdx2 decreased the Cdx2 protein expression compared with transfection of the negative control ( Figure 6B) . Correspondingly, the transfection of siRNA for Cdx2 resulted in an increase in Shh mRNA compared with the negative control ( Figure 6B ).
To further address the effect of Cdx2 on Shh expression, Cdx2-deletion mutant plasmids were produced. Cdx2 contains a central nuclear localization signal, a downstream homeodomain and a C-terminal domain. We constructed a C-terminal-deleted mutant of Cdx2 (Cdx2 C) that contained the nuclear localization signal and homeodomain but lacked the C-terminal domain ( Figure 6C ). Full-length Cdx2 and Cdx2 C were transfected into AGS cells. Extracted proteins were detected by Western blotting using anti-Cdx2 antibody. Full-length Cdx2 and Cdx2 C were equally expressed in the transfected AGS cells ( Figure 6C) . To examine the effect of the two Cdx2 expression plasmids on the transcriptional activity, we used the Math1 reporter luciferase vector as reported previously [20] . Co-transfection of full-length Cdx2 or Cdx2 C with the Math1 reporter plasmid resulted in an almost identical increase in transcriptional activity ( Figure 6C) .
Next, we transfected the Cdx2 or Cdx2 C expression plasmids into AGS, MKN45 and MKN74 cells and measured Shh mRNA levels using qRT-PCR. Compared with the transfection of a control vector (pRV/CMV), the transfection of the Cdx2 expression plasmid resulted in a decrease in Shh mRNA, whereas the transfection of Cdx2 C plasmid did not affect the Shh expression ( Figure 6D) .
We then examined the ability of Cdx2 to bind to the TATA sequence of the Shh promoter in these cells by ChIP assays using qRT-PCR. Compared with control IgGs, antibodies against Cdx2 precipitated the DNA containing the TATA sequence (TATATAG) in all three cell lines ( Figure 6E ). Furthermore, we examined the ability of Cdx2 to bind to the human SHH promoter sequence, 616 bp upstream from the transcription start site (for primers see Table 1 ); no PCR products were detected (results not shown).
The transcriptional activity of an Shh promoter reporter construct, containing the region between residues − 792 and Table 1 ). The base positions relative to the transcription start site of the mouse Shh gene are shown on the left-hand side. (B) qRT-PCR for ChIP assays using Shh-ChIP-fw-2, Shh-ChIP-rv-2 and TaqMan-MGB-probe-2. Normal mouse stomach, normal mouse intestine and Cdx2-transgenic mouse stomach [pedigrees no. 17 (Cdx2#17) and no. 53 (Cdx2#53)] were subjected to ChIP assays, followed by qRT-PCR to quantify the level of the precipitated target sequence DNA. The results are expressed as the fold enrichment in DNA precipitated with 10 μg of anti-Cdx2 antibody (Anti-Cdx2 +) compared with that in the control DNA samples precipitated with equivalent amounts of IgG (IgG +; control values normalized to 1). (C) qRT-PCR as for (B) using Shh-ChIP-fw-1, Shh-ChIP-rv-1 and TaqMan-MGB-probe-1. (D) EMSA. A radiolabelled dsDNA probe containing the TATATA sequence, or a similar probe with a mutation in the Shh promoter was incubated with nuclear extracts from AGS cells transfected with full-length Cdx2 or Cdx2 C, and separated by PAGE on a 5 % gel. The competition assay was performed using labelled wild-type sequence as probe and an 100 × excess of unlabelled competitor or unlabelled mutant competitor. Lane 1, wild-type probe and non-transfected extract; lane 2, wild-type probe and Cdx2-transfected extract; lane 3, mutant probe and Cdx2-transfected extract; lane 4: wild-type probe, Cdx2-transfected extract and unlabelled competitor; lane 5: wild-type probe, Cdx2-transfected extract and unlabelled mutant competitor; and lane 6, mutant probe and mutant Cdx2-transfected extract.
+133, was reduced compared with the pGL4.10[luc2] control construct, whereas the activity of a Shh promoter reporter gene, containing the region between − 792 and − 30, was not reduced, in Cdx2-expressing AGS, MKN45 and MKN74 cells ( Figure 6F ). This suggests that an element located between residues − 30 and +133 in the Shh promoter may be critical for Shh gene transcriptional repression in Cdx2-expressing AGS, MKN45 and MKN74 cells. The sequence between − 30 and +133 contains a potential Cdx2-binding site (TATATAG, at − 18 to − 12). Analysis of a reporter construct with a mutation of this Cdx2-consensus-binding element revealed that this element was critical for transcriptional reduction of the Shh reporter gene construct in AGS, MKN45 and MKN74 cells ( Figure 6F) .
Furthermore, we examined the effects of transfection of the Cdx2 expression plasmid, the Cdx2 C expression plasmid or siRNA targeting Cdx2 on the transcriptional activities of the Shh promoter luciferase construct containing the region between − 792 and +133 and the mutant Shh reporter luciferase construct. Co-transfection with the Cdx2 expression plasmid decreased the transcriptional activity of the intact Shh reporter gene, but did not affect the transcriptional activity of the mutant Shh reporter gene in AGS, MKN45 and MKN74 cells ( Figures 6G  and 6H ). Co-transfection with the Cdx2 C expression plasmid also did not affect the transcriptional activity of the intact or the mutant Shh reporter genes in AGS, MKN45 and MKN74 cells ( Figures 6G and 6H ). Co-transfection with siRNA against Cdx2 increased the transcriptional activity of the intact Shh reporter gene, but did not affect the transcriptional activity of the mutant Shh reporter gene in AGS, MKN45 and MKN74 cells (Figures 6G and 6H) . 
DISCUSSION
The present study has confirmed that Shh expression is lost in the intestinal metaplastic lesions of the Cdx2-transgenic mouse stomach, as was shown previously in human intestinal metaplasia [3, 16] . Furthermore, the expression of the downstream target gene Bmp4 was also reduced. We have shown that Cdx2 down-regulated Shh expression directly by binding to the Cdx2-consensus cis-regulatory element in the unmethylated Shh promoter region. This loss of Shh expression was induced by the overexpression of Cdx2 and, in turn, was associated with the loss of parietal cells and abnormal fundic gland cell differentiation. The present results suggest that Cdx2, which is usually induced by H. pylori infection, prevents the normal fundic gland differentiation by reducing the expression of Shh and transforms normal gastric mucosa to an intestinal metaplastic phenotype.
van den Brink et al. [2] reported that Shh was highly expressed in the parietal cells of the gastric fundic glands in humans and mice and that the expression was correlated with fundic gland differentiation through the induction of the downstream target Bmp4 in the mesenchyme. Bmp4 is a potent inducer of ATP4a gene expression [21] (Figure 7 ) and promotes the induction and maintenance of a differentiated parietal cell phenotype. Inhibition of Shh signalling in the gastric mucosa has been reported to lead to diminished expression of Bmp4 [2] . The present study also indicates that reduced Shh expression downregulated Bmp4 expression in the intestinal metaplastic mucosa of Cdx2-transgenic mouse stomach (Figure 7 ). Bmp4 might be able to rescue ATP4a gene expression, but it cannot prevent or reverse the development of intestinal metaplasia in Cdx2-expressing gastric mucosa, because the intestinal phenotype will be induced by Cdx2 even if Bmp4 is present. Loss of Shh and aberrant Cdx2 expression may be closely related to the generation of intestinal metaplasia. Furthermore, we previously reported that CDX2 expression was observed in H. pylori-infected human gastric mucosa, before morphological intestinal metaplasia was evident [11] . The results indicate that Cdx2 might reduce Shh expression even before morphological intestinal metaplasia is observed.
Bmp2 expression was also reduced in the intestinal metaplastic mucosa of Cdx2-transgenic mouse stomach, despite the fact that Bmp2 is not a target of the Shh signal transduction pathway. Bmp2 plays an important role during digestive organ development, including stomach gland formation [22] , and is highly expressed in the normal human stomach [2] . Therefore in the intestinal metaplastic mucosa of the Cdx2-transgenic mouse stomach, which has lost the normal gastric differentiation, Bmp2 levels might be reduced by a mechanism other than via down-regulation of Shh.
Other Shh targets, Gli1 and Ptch1, were also down-regulated in the intestinal metaplastic mucosa of Cdx2-transgenic mouse stomach. However, expression of Gli1 and Ptch1 was not completely down-regulated, whereas Shh expression was completely absent. Gli1 and Ptch1 are downstream targets of Shh, as well as Ihh. The presence of normal Ihh levels may underlie the residual expression of Gli1 and Ptch1. This may also be the reason behind the incomplete down-regulation of Bmp4.
Epigenetic inactivation, in particular aberrant DNA hypermethylation, is an important mechanism for gene silencing. However, in the present study, we demonstrated that the Shh promoter was unmethylated in both the normal gastric mucosa and the intestinal metaplastic mucosa, indicating that loss of Shh expression in the intestinal metaplastic mucosa is not associated with promoter hypermethylation. Cdx2 protein binds to the consensus sequence C/TATAAAT/G [23] . In some instances, the Cdxbinding site shows a high level of similarity to the canonical TATA box sequence, and indeed the Cdx2 proteins have been shown to be able to bind to the TATA boxes of some intestinal genes, such as that of the Cabp9k [calbindin-D9K; also known as S100g (S100 calcium-binding protein G)] gene [24] , the clusterin gene [25] and the glucose-6-phosphatase gene [26] . In the present study, CpGs in the region of the TATATAG sequence, located at − 18 to − 12 bp upstream of the transcription start site, were unmethylated in the normal gastric and the intestinal metaplastic mucosa. The ChIP assay indicated that Cdx2 is present on this Shh promoter region. Furthermore, analysis of reporter constructs with deletions or mutations of the Shh promoter region revealed that this element was critical for transcriptional activity of a Shh reporter gene construct.
Cdx2 is an intestine-specific transcription factor that acts as a master regulator for intestinal development and differentiation. For example, loss of Cdx2 expression leads to focal areas of gastric differentiation in the colon [27] . We generated Cdx2-transgenic mice with stomach-specific expression of Cdx2 previously, and showed these mice developed intestinal metaplastic mucosa in the stomach [13, 14] . Cdx2 expression in the intestinal metaplastic mucosa induces the intestinal phenotype in the gastric mucosa. However, it remained unclear why the gastric phenotype is lost in the intestinal metaplastic mucosa of both human and Cdx2-transgenic mouse stomachs. The present study has clarified the mechanism by which the intestinal phenotype is induced and the gastric phenotype is lost in the intestinal metaplastic mucosa. In our proposed mechanism, Cdx2 has two functions: (i) Cdx2 induces the intestinal phenotype through directly transactivating intestine-specific genes; and (ii) Cdx2 represses the gastric phenotype by reducing the expression of gastric-specific genes via a reduction in Shh (Figure 7) . These results are in accordance with results showing that Shh expression is increased in fundic gland ectopies, such as Meckel's diverticulum, where Cdx2 is lost [3] .
Mucous neck cells migrate from the stem cell position in the gastric unit towards the base of the gastric glands. As these cells migrate downwards, they transdifferentiate from mucous neck cells to zymogenic cells. Muc6 expression is reportedly limited to the mucous neck cells of the fundus [28] . Muc6 is identical with the class III mucin detected by paradoxical concanavalin A staining [29] . It has been shown that Muc6 production is turned off as the mucous neck cells migrate towards the base of the fundic glands and transdifferentiate into pepsinogen-producing zymogenic cells [19] . In the Cdx2-transgenic mouse stomach, there was a loss of parietal cells and the distribution of the Muc6-positive cells showed a marked shift towards the base of the fundic glands, indicating a failure of the mucous neck cells to transdifferentiate fully into zymogenic cells [13] . The expression level of Ihh was not altered in the intestinal metaplastic mucosa of Cdx2-transgenic mouse stomach. This indicates that the loss of Shh in the intestinal metaplastic mucosa is a primary effect of the transgene, not secondary to the loss of parietal cells.
Several transcription factors including Cdx2 have been reported to bind to the TATA box and down-regulate the transcriptional activity of target genes. Cdx2 exerts an inhibitory effect on the activity of the Cdx1 promoter [30] and forced expression of Cdx2 reduces the level of Cdx1 mRNA in colon cancer cells [31] . Cdx2 binds to the TATA box of the Cabp9k gene that is mainly expressed in differentiated duodenal epithelial cells [24] . Cdx2 represses the transcriptional activity of the CaBP9k gene in HeLa cells, which do not express Cdx2, whereas Cdx2 does not repress CaBP9k gene expression in cells of intestinal origin that contain endogenous Cdx2 [24] . In addition to Cdx2, other homeodomain proteins, such as En (engrailed) [32] and Eve (evenskipped) [33] , bind to the TATA boxes, competing with the TATAbox-binding protein TFIID (transcription factor IID) and repressing the transcription of their target genes. These results suggest that the transcriptional repression of the Shh gene by Cdx2 might be caused by competition with the TFIID for binding to the TATA box and the prevention of the formation of the pre-initiation complex. On the other hand, the Cabp9k promoter possesses a specialized TATA box that co-operates with the surrounding sequence to determine intestine-specific transcription [24] . The pituitary-specific GHF-1 (growth hormone factor-1) gene [34] and the neuron-specific peripherin gene [35] use the same mechanism to determine cell-type-specific transcriptional repression, and this might also apply to Cdx2-mediated repression of Shh.
In conclusion, we propose that Shh is directly down-regulated by Cdx2 in the intestinal metaplastic mucosa via Cdx2 binding to the Cdx2-consensus cis-regulatory element of the unmethylated Shh promoter. The down-regulation of Shh and its downstream target gene Bmp4 in the Cdx2-induced intestinal metaplastic mucosa may cause the loss of the gastric phenotype.
